The Race to Develop Therapeutics for COVID. The Small Caps Fight for a Treatment...
The Second Wave: Biopharma Players Race to Develop Therapeutics for COVID-19 (BioSPace) December 21.
Revive Therapeutics (RVTTF), RedHill BioPharma...
News and Charts on Four Small Cap Telehealth and Remote Health Monitoring Plays.
After Losing $33 Billion in Value, Teladoc Health Snags an Upgrade.
With chances building...
Reuniting With the Affable Mr. Greg Halpern, 19 Years Later…
A Potential Christmas Present Arrives in our lap Early, From the Inventor of Crowdfunding and Winner of Incubator of The Year in...
VYRE Streaming Network Partners with UNIFD.
With Clients Like McDonald's, Budweiser, CBS Sports, Norton and Intuit-TurboTax, "UNIFD is the Largest Independent Audio & Connected TV Marketplace, Period."
VYRE Network (CAPV) Now Integrated With Samsung TV
Las Vegas, Nevada--(Newsfile Corp. - December 10, 2021) - VYRE Network (OTC Pink: CAPV) (a wholly-owned Cabo Verde Capital company, "VYRE") is pleased to announce that...
Adding VYRE Network (CAPV) to the Watch List.
Look What We Found. Our First Internet Play in Ages, And It's a Doozy.
We would categorize this...
Interview: Ric Schumacher CEO, Pressure Bioscience (PBIO)
Our favorite interview to date, and there have been dozens. Filmed November of 2021, and the story has gotten to much better...
Dicerna (DRNA) up 78% Today. Being Acquired by Novo Nordisk (NVO) for $38.00.
We shoot and we score. Up 1,133% since adding to Watch List @ $3.00.
Our second...
The Alkaline Water Company (WTER) Reports Record Second Quarter Revenue with 50% Year over...
$15.25 Million in Revenue is Best Quarter in Company History
SCOTTSDALE, Ariz., November 09, 2021–(BUSINESS WIRE)–The Alkaline Water Company...
Adding Beach Body (BODY) $3.90 to the Watch List.
This is Like Shooting Fish in the Barrell, but the Fish Shoot Back.
We’re not traders, but we...
Latest article
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.
CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...
GeoVax (GOVX) Launches Vaccine Manufacturing System.
GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System
Manufacturing Process for Phase 3 and Commercial Production...
